Novartis cannot block generic of best-selling heart drug, US appeals court says
Novartis failed to convince a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals’ proposed generic of Novartis’ blockbuster heart drug Entresto.
Related Articles
Interventions for the management of long covid (post-covid condition): living systematic review
Objective To compare the effectiveness of interventions for the management of long covid (post-covid condition). Design Living systematic review. Data sources Medline, Embase, CINAHL, PsycInfo,…
Pakistani airstrikes on Afghanistan kill 46 people, Taliban official says
Bombardment by Pakistani military aircraft in Afghanistan’s eastern Paktika province on Tuesday killed at least 46 people, most of whom were children and women, the…
Tips on taking care of your skin during cold weather
Your skin deserves some extra love this winter! Tune in to this @9news segment as I share tips to protect and nourish your skin during…
Uncertainty clouds fate of Syrians in Egypt after Assad ouster
Syrian refugees and residents in Egypt face an uncertain future as new regulations may jeopardise their right to remain in the country after Bashar al-Assad’s…
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | NEJM
Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor…
Ukraine collects vast war data trove to train AI models
As the future of warfare pivots towards artificial intelligence, Ukraine is sitting on a valuable resource: millions of hours of footage from drones which can…
Prediction of metabolic subphenotypes of type 2 diabetes via continuous glucose monitoring and machine learning
Nature Biomedical Engineering – Metabolic subphenotypes of type 2 diabetes can be predicted by the shape of the glucose curve measured via a continuous glucose…
Nigeria activates emergency response as Lassa fever kills 190 this year
Nigeria has launched an emergency response centre after recording 190 deaths from Lassa fever, a viral hemorrhagic illness, the country’s disease control agency said on…
AstraZeneca withdraws application for lung cancer drug in EU
AstraZeneca has voluntarily withdrawn its marketing authorisation application with the EU’s medicines regulator for its experimental precision drug for the treatment of a type of…
Ukraine says it has laser weapon able to down targets flying at over 2km
Ukraine possesses a laser weapon capable of shooting down airborne targets at an altitude of more than 2 kilometres (1.2 miles), the country’s drone forces…
